RWE & HTA Strategy Manager - UK Access

Pfizer Inc.

Knaphill

On-site

GBP 70,000 - 95,000

Full time

11 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Benefits offered by this job

Pfizer benefits

Job summary

Pfizer is seeking a Manager-level professional to lead the development of an optimized evidence strategy for HTA submissions in the UK. You will identify evidence gaps, plan and execute RWE studies, and align with UK launch and global strategies.

You will collaborate with HTA, A&A, and O&E teams to drive reimbursement and access outcomes. With senior support to enhance research methods, you will manage observational studies using UK databases, maintain stakeholder relationships, and ensure

Qualifications

  • Post-graduate qualification in epidemiology, public health, or a related field.
  • Experience in RWE and HTA/market access, ideally in industry or consultancy.
  • Observational research using UK databases (e.g., CPRD/HES/SACT) with study design and analysis knowledge.
  • Excellent project management, strategic and analytical skills with strong interpersonal abilities.
  • Proven stakeholder management skills to align evidence strategies.

Responsibilities

  • Lead evidence gap analyses and develop evidence strategies for therapy areas.
  • Collaborate with Outcomes Research scientists to define patient-centered requirements for reimbursement.
  • Create compelling business cases to secure funding for studies and show impact on access outcomes.
  • Manage RWE projects from conception to dissemination, including vendors or internal teams, ensuring compliance.
  • Maintain relationships with cross-functional teams to keep evidence plans aligned with business goals.
  • Stay updated on UK datasets, platforms, and RWE methods to improve evidence generation.
  • Source or provide training to develop RWE methodology skills.

Job description

Pfizer is seeking a Manager-level professional to lead the development of an optimized evidence strategy for HTA submissions in the UK. You will identify evidence gaps, plan and execute RWE studies, and align with UK launch and global strategies.

You will collaborate with HTA, A&A, and O&E teams to drive reimbursement and access outcomes. With senior support to enhance research methods, you will manage observational studies using UK databases, maintain stakeholder relationships, and ensure

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

UK Access & Value: RWE & HTA Strategy Lead
UK Access & Value: RWE & HTA Strategy Lead

Pfizer • Tadworth

On-site
GBP 90,000 - 120,000
UK Market Access & Evidence Lead
UK Market Access & Evidence Lead

Pfizer • United Kingdom

Hybrid
GBP 65,000 - 90,000
Access & Value (A&V), Outcomes and Evidence (O&E) Manager
Access & Value (A&V), Outcomes and Evidence (O&E) Manager

Pfizer Inc. • Knaphill

On-site
GBP 70,000 - 95,000
Pfizer benefits
Access & Value (A&V), Outcomes and Evidence (O&E) Manager
Access & Value (A&V), Outcomes and Evidence (O&E) Manager

Pfizer • United Kingdom

Hybrid
GBP 65,000 - 90,000
Access & Value (A&V), Outcomes and Evidence (O&E) Manager
Access & Value (A&V), Outcomes and Evidence (O&E) Manager

Pfizer • Tadworth

On-site
GBP 90,000 - 120,000
UK Market Access Lead – Oncology HTA & Reimbursement
UK Market Access Lead – Oncology HTA & Reimbursement

Genmab • Greater London

On-site
GBP 80,000 - 120,000
Pension
Health insurance and wellness benefits
Paid time off
+1
UK Market Access Lead — HTA & Dossier Strategy
UK Market Access Lead — HTA & Dossier Strategy

Genmab • City of Westminster

On-site
GBP 80,000 - 120,000
Pension
Health insurance and wellness benefits
Paid time off
+1
UK Market Access Director: Pricing & Strategy
UK Market Access Director: Pricing & Strategy

Moderna Therapeutics • Greater London

Hybrid
GBP 140,000 - 200,000
Competitive healthcare
Family building benefits
Generous paid time off
Global HEOR Lead: Evidence & Market Access Strategy
Global HEOR Lead: Evidence & Market Access Strategy

Grünenthal Group • Maidenhead

On-site
GBP 80,000 - 120,000
RWE Strategy Lead: Patient Impact & Access
RWE Strategy Lead: Patient Impact & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000